Inventor · disambiguated record
James A. Williams
Also filed as: WILLIAMS JAMES · WILLIAMS JAMES A · WILLIAMS JAMES ARTHUR
36 granted patents·25 pending applications·617 citations·filing 1993–2025
98Inventor score
Files withNATURE TECH CORPORATION9WILLIAMS JAMES A9NATURE TECH CORP6ALLERGAN SALES INC ALLERGAN BO5OPHIDIAN PHARM INC5
Top patents by PatentIndex Score
61 records- 0197US10167478B2Replicative minicircle vectors with improved expressionNATURE TECH CORPORATION·Filed 2016·Granted Jan 1, 2019·9 cites·15 claims
- 0297US9550998B2DNA plasmids with improved expressionNATURE TECH CORP·Filed 2013·Granted Jan 24, 2017·38 cites·1 claims
- 0397US5919665AVaccine for clostridium botulinum neurotoxinOPHIDIAN PHARM INC·Filed 1995·Granted Jul 6, 1999·198 cites·10 claims
- 0495US10047365B2Replicative minicircle vectors with improved expressionNATURE TECH CORPORATION·Filed 2013·Granted Aug 14, 2018·10 cites·7 claims
- 0594US9737620B2Vectors and methods for genetic immunizationNATURE TECH CORP·Filed 2015·Granted Aug 22, 2017·8 cites·6 claims
- 0693US11098313B2Replicative minicircle vectors with improved expressionNATURE TECH CORPORATION·Filed 2018·Granted Aug 24, 2021·4 cites·4 claims
- 0793US10844388B2Replicative minicircle vectors with improved expressionNATURE TECH CORPORATION·Filed 2018·Granted Nov 24, 2020·4 cites·5 claims
- 0892US11851665B2Replicative minicircle vectors with improved expressionALDEVRON L L C·Filed 2020·Granted Dec 26, 2023·2 cites·4 claims
- 0989US9109012B2Vectors and method for genetic immunizationWILLIAMS JAMES A·Filed 2008·Granted Aug 18, 2015·7 cites·18 claims
- 1089US6573003B2Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile diseasePROMEGA CORP·Filed 2001·Granted Jun 3, 2003·15 cites·4 claims
- 1189US5601823AAvian antitoxins to clostridium difficle toxin AOPHIDIAN PHARM INC·Filed 1993·Granted Feb 11, 1997·81 cites·15 claims
- 1288USRE49423EDNA plasmids with improved expressionNATURE TECH CORPORATION·Filed 2020·Granted Feb 21, 2023·1 cites·14 claims
- 1388US9506082B2Eukaryotic expression vectors resistant to transgene silencingWILLIAMS JAMES A·Filed 2011·Granted Nov 29, 2016·5 cites·7 claims
- 1488US9017966B2E. coli plasmid DNA productionWILLIAMS JAMES A·Filed 2008·Granted Apr 28, 2015·8 cites·14 claims
- 1588US7943377B2Process for plasmid DNA fermentationNATURE TECHNOLOGY CORP·Filed 2005·Granted May 17, 2011·12 cites·7 claims
- 1687US10144935B2DNA plasmids with improved expressionNATURE TECH CORPORATION·Filed 2016·Granted Dec 4, 2018·2 cites·7 claims
- 1787US2024218382A1Replicative minicircle vectors with improved expressionALDEVRON L L C·Filed 2023·Application pending·0 cites
- 1886US9950081B2Vectors and methods for genetic immunizationNATURE TECH CORPORATION·Filed 2015·Granted Apr 24, 2018·2 cites·12 claims
- 1986US9012226B2Bacterial strains with improved plasmid stabilityWILLIAMS JAMES A·Filed 2010·Granted Apr 21, 2015·5 cites·5 claims
- 2081US9018012B2Vectors and methods for genetic immunizationWILLIAMS JAMES A·Filed 2006·Granted Apr 28, 2015·1 cites·8 claims
- 2181US6080400ACompositions for the prevention and treatment of verotoxin-induced diseaseOPHIDIAN PHARM INC·Filed 1997·Granted Jun 27, 2000·40 cites·2 claims
- 2280US5762934AClostridium difficile toxin disease therapyOPHIDIAN PHARM INC·Filed 1995·Granted Jun 9, 1998·45 cites·16 claims
- 2380US2023242924A1DNA Plasmids with Improved ExpressionNATURE TECH CORPORATION·Filed 2022·Application pending·0 cites
- 2479US9045759B2DNA plasmids with improved copy numberWILLIAMS JAMES ARTHUR·Filed 2010·Granted Jun 2, 2015·4 cites·2 claims
- 2579US6967088B1Soluble recombinant botulinum toxin proteinsALLERGAN BOTOX LTD·Filed 1996·Granted Nov 22, 2005·36 cites·7 claims
- 2674US5814477ARecombinant clostridial toxin proteinOPHIDIAN PHARM INC·Filed 1995·Granted Sep 29, 1998·33 cites·5 claims
- 2773US9725725B2E. coli plasmid DNA productionNATURE TECH CORP·Filed 2015·Granted Aug 8, 2017·1 cites·9 claims
- 2873US6652857B2Methods for producing avian verotoxin antitoxinPROMEGA CORP·Filed 1999·Granted Nov 25, 2003·24 cites·4 claims
- 2972US9951368B2Methods of DNA constructs for high yield production of polypeptidesMEDTRONIC INC·Filed 2016·Granted Apr 24, 2018·1 cites·20 claims
- 3071US7501484B2Methods and DNA constructs for high yield production of polypeptidesRESTORAGEN INC·Filed 2004·Granted Mar 10, 2009·3 cites·17 claims
- 3171US2025387343A1Nanoparticle Compositions and Methods for Synthesis ThereofICEUTICA PTY LTD·Filed 2025·Application pending·0 cites
- 3269US2007269861A1Soluble recombinant botulinum toxin proteinsALLERGAN INC ALLERGAN BOTOX LT·Filed 2006·Application pending·0 cites
- 3369US2005238665A1Soluble recombinant botulinum toxin proteinsALLERGAN INC ALLERGAN BOTOX LT·Filed 2004·Application pending·0 cites
- 3467US2015322439A1Replicative minicircle vectors with improved expressionWILLIAMS JAMES A·Filed 2013·Application pending·0 cites
- 3566US2020360294A1Nanoparticle Compositions and Methods for Synthesis ThereofICEUTICA PTY LTD·Filed 2020·Application pending·0 cites
- 3666US2004142455A1Recombinant botulinum toxins having a soluble C-terminal portion of a heavy chain, an N-terminal portion of a heavy chain and a light chainALLERGAN SALES INC ALLERGAN BO·Filed 2003·Application pending·0 cites
- 3766US2004219637A1Soluble recombinant botulinum toxins having a C-terminal portion of a heavy chain, a N-terminal portion of a heavy chain and a light chainALLERGAN SALES INC ALLERGAN BO·Filed 2003·Application pending·0 cites
- 3866US2004115215A1Recombinant botulinum toxins with a soluble C-terminal portion, an N-terminal portion and a light chainALLERGAN SALES INC ALLERGAN BO·Filed 2003·Application pending·0 cites
- 3966US2004253673A1Recombinant botulinum toxins with a soluble C-terminal portionALLERGAN SALES INC ALLERGAN BO·Filed 2003·Application pending·0 cites
- 4066US2004235118A1Portions of soluble recombinant botulinum toxinsALLERGAN INC ALLERGAN BOTOX LT·Filed 2003·Application pending·0 cites
- 4165US2023132250A1Bacterial host strainsNATURE TECH CORPORATION·Filed 2022·Application pending·0 cites
- 4263US9322025B2Methods and DNA constructs for high yield production of polypeptidesWILLIAMS JAMES A·Filed 2009·Granted Apr 26, 2016·0 cites·31 claims
- 4363US2003219457A1Soluble recombinant botulinum toxinsALLERGAN SALES INC ALLERGAN BO·Filed 2002·Application pending·0 cites
- 4462US12215335B2Non-integrating DNA vectors for the genetic modification of cellsDEUTSCHES KREBSFORSCH·Filed 2018·Granted Feb 4, 2025·0 cites·27 claims
- 4562US2023346976A1Muscle-specific hybrid promoterALDEVRON L L C·Filed 2023·Application pending·0 cites
- 4660US6365158B1Methods for producing neutralizing antitoxin to C. difficile toxin BPROMEGA CORP·Filed 1997·Granted Apr 2, 2002·8 cites·17 claims
- 4760US2003215468A1Soluble recombinant botulinum toxin proteinsALLERGAN INC ALLERGAN BOTOX LT·Filed 2003·Application pending·0 cites
- 4858US9487789B2E. coli plasmid DNA productionNATURE TECH CORP·Filed 2015·Granted Nov 8, 2016·0 cites·1 claims
- 4958US9487788B2E. coli plasmid DNA productionNATURE TECH CORP·Filed 2015·Granted Nov 8, 2016·0 cites·3 claims
- 5058US2020263195A1Non-integrating dna vectors for the genetic modification of cellsDEUTSCHES KREBSFORSCH·Filed 2018·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James A. Williams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →